416 related articles for article (PubMed ID: 31359615)
1. Dispensation of antiretroviral therapy and methadone maintenance therapy at the same facility in a low-barrier setting linked to optimal adherence to HIV treatment.
Mohd Salleh NA; Fairbairn N; Nolan S; Barrios R; Shoveller J; Richardson L; Milloy MJ
HIV Med; 2019 Oct; 20(9):606-614. PubMed ID: 31359615
[TBL] [Abstract][Full Text] [Related]
2. Dose-response relationship between methadone dose and adherence to antiretroviral therapy among HIV-positive people who use illicit opioids.
Lappalainen L; Nolan S; Dobrer S; Puscas C; Montaner J; Ahamad K; Dong H; Kerr T; Wood E; Milloy MJ
Addiction; 2015 Aug; 110(8):1330-9. PubMed ID: 25940906
[TBL] [Abstract][Full Text] [Related]
3. A Longitudinal Analysis of Daily Pill Burden and Likelihood of Optimal Adherence to Antiretroviral Therapy Among People Living With HIV Who Use Drugs.
Mohd Salleh NA; Richardson L; Kerr T; Shoveller J; Montaner J; Kamarulzaman A; Milloy MJ
J Addict Med; 2018; 12(4):308-314. PubMed ID: 29521670
[TBL] [Abstract][Full Text] [Related]
4. Factors linked to transitions in adherence to antiretroviral therapy among HIV-infected illicit drug users in a Canadian setting.
Joseph B; Kerr T; Puskas CM; Montaner J; Wood E; Milloy MJ
AIDS Care; 2015; 27(9):1128-36. PubMed ID: 25915438
[TBL] [Abstract][Full Text] [Related]
5. Predictors of accessing antiretroviral therapy among HIV-positive drug users in China's National Methadone Maintenance Treatment Programme.
Zhao Y; Shi CX; McGoogan JM; Rou K; Zhang F; Wu Z
Addiction; 2015 Jan; 110 Suppl 1(Suppl 1):40-50. PubMed ID: 25533863
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and Correlates of Reporting Difficulty Taking Antiretroviral Treatment Among HIV-Positive Illicit Drug Users in Vancouver, Canada: A Longitudinal Analysis.
Yeung B; Mohd Salleh NA; Socías E; Dong H; Shoveller J; Montaner JSG; Milloy MS
AIDS Behav; 2019 May; 23(5):1250-1257. PubMed ID: 30284081
[TBL] [Abstract][Full Text] [Related]
7. Viral suppression among HIV-infected methadone-maintained patients: The role of ongoing injection drug use and adherence to antiretroviral therapy (ART).
Shrestha R; Copenhaver MM
Addict Behav; 2018 Oct; 85():88-93. PubMed ID: 29879611
[TBL] [Abstract][Full Text] [Related]
8. High-intensity cannabis use and adherence to antiretroviral therapy among people who use illicit drugs in a Canadian setting.
Slawson G; Milloy MJ; Balneaves L; Simo A; Guillemi S; Hogg R; Montaner J; Wood E; Kerr T
AIDS Behav; 2015 Jan; 19(1):120-7. PubMed ID: 25012624
[TBL] [Abstract][Full Text] [Related]
9. Unintended impacts of regulatory changes to British Columbia Methadone Maintenance Program on addiction and HIV-related outcomes: An interrupted time series analysis.
Socías ME; Wood E; McNeil R; Kerr T; Dong H; Shoveller J; Montaner J; Milloy MJ
Int J Drug Policy; 2017 Jul; 45():1-8. PubMed ID: 28454044
[TBL] [Abstract][Full Text] [Related]
10. Methadone maintenance therapy and viral suppression among HIV-infected opioid users: The impacts of crack and injection cocaine use.
Socías ME; Wood E; Small W; Dong H; Shoveller J; Kerr T; Montaner J; Milloy MJ
Drug Alcohol Depend; 2016 Nov; 168():211-218. PubMed ID: 27701042
[TBL] [Abstract][Full Text] [Related]
11. Methadone maintenance therapy decreases the rate of antiretroviral therapy discontinuation among HIV-positive illicit drug users.
Reddon H; Milloy MJ; Simo A; Montaner J; Wood E; Kerr T
AIDS Behav; 2014 Apr; 18(4):740-6. PubMed ID: 23918244
[TBL] [Abstract][Full Text] [Related]
12. Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: a longitudinal analysis.
Azar P; Wood E; Nguyen P; Luma M; Montaner J; Kerr T; Milloy MJ
BMC Infect Dis; 2015 Apr; 15():193. PubMed ID: 25927573
[TBL] [Abstract][Full Text] [Related]
13. HIV-Related Stigma, Motivation to Adhere to Antiretroviral Therapy, and Medication Adherence Among HIV-Positive Methadone-Maintained Patients.
Shrestha R; Altice FL; Copenhaver MM
J Acquir Immune Defic Syndr; 2019 Feb; 80(2):166-173. PubMed ID: 30383588
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal patterns of illicit drug use, antiretroviral therapy exposure and plasma HIV-1 RNA viral load among HIV-positive people who use illicit drugs.
Liang J; Nosova E; Reddon H; Nolan S; Socías E; Barrios R; Milloy MJ
AIDS; 2020 Jul; 34(9):1389-1396. PubMed ID: 32590435
[TBL] [Abstract][Full Text] [Related]
15. Negotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: A qualitative study.
McNeil R; Kerr T; Anderson S; Maher L; Keewatin C; Milloy MJ; Wood E; Small W
Soc Sci Med; 2015 May; 133():168-76. PubMed ID: 25875323
[TBL] [Abstract][Full Text] [Related]
16. Material security and adherence to antiretroviral therapy among HIV-positive people who use illicit drugs.
Mohd Salleh NA; Van Draanen J; Nosova E; Barrios R; Milloy MJ; Richardson L
AIDS; 2020 Jun; 34(7):1037-1045. PubMed ID: 32073444
[TBL] [Abstract][Full Text] [Related]
17. Homelessness and adherence to antiretroviral therapy among a cohort of HIV-infected injection drug users.
Palepu A; Milloy MJ; Kerr T; Zhang R; Wood E
J Urban Health; 2011 Jun; 88(3):545-55. PubMed ID: 21409604
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with methadone maintenance therapy discontinuation among people who inject drugs.
Lo A; Kerr T; Hayashi K; Milloy MJ; Nosova E; Liu Y; Fairbairn N
J Subst Abuse Treat; 2018 Nov; 94():41-46. PubMed ID: 30243416
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of integrating methadone maintenance and antiretroviral treatment for HIV-positive drug users in Vietnam's injection-driven HIV epidemics.
Tran BX; Ohinmaa A; Duong AT; Nguyen LT; Vu PX; Mills S; Houston S; Jacobs P
Drug Alcohol Depend; 2012 Oct; 125(3):260-6. PubMed ID: 22436971
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with optimal pharmacy refill adherence for antiretroviral medications and plasma HIV RNA non-detectability among HIV-positive crack cocaine users: a prospective cohort study.
Hayashi K; Wood E; Kerr T; Dong H; Nguyen P; Puskas CM; Guillemi S; Montaner JS; Milloy MJ
BMC Infect Dis; 2016 Aug; 16(1):455. PubMed ID: 27568002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
